48146 Federal Register / Vol. 86, No. 164 / Friday, August 27, 2021 / Notices 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Health care providers ...................................... Study screener ............................................... 1,138 1 10/60 

Web-based survey ......................................... 569 1 15/60 

Exploratory Guide—Prevention with Positives 

In-depth Interview.

95 1 1 

Exploratory Guide—Patient Centered Care 

In-depth Interview.

95 1 1 

Exploratory Guide—HIV Prevention In-depth 

Interview.

95 1 1 

Message Testing In-depth Interview Guide ... 95 1 1 

Concept Testing In-depth Interview Guide .... 95 1 1 

Materials Testing In-depth Interview .............. 95 1 1 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2021–18540 Filed 8–26–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–21–0600; Docket No. CDC–2021– 

0087] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

proposed information collection project 

titled CDC Model Performance 

Evaluation Program (MPEP) for 

Mycobacterium tuberculosis 

Susceptibility Testing information 

collection. CDC is requesting a threeyear approval for revision to the 

previously approved project used to 

monitor and evaluate performances and 

practices among national laboratories 

for M. tuberculosis susceptibility 

testing. 

DATES: CDC must receive written 

comments on or before October 26, 

2021. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2021– 

0087 by any of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS–D74, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

Regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS– 

D74, Atlanta, Georgia 30329; phone: 

404–639–7570; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

CDC Model Performance Evaluation 

Program (MPEP) for Mycobacterium 

tuberculosis Susceptibility testing (OMB 

Control No. 0920–0600, Exp. 2/20/ 

2022)—Revision—National Center for 

HIV/AIDS, Viral Hepatitis, STD, and TB 

Prevention (NCHHSTP), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

The Centers for Disease Control and 

Prevention (CDC) is requesting a 

revision to approved information 

collection from participants in the CDC 

Model Performance for Mycobacterium 

tuberculosis Drug Susceptibility Testing 

Program for a period of three years. 

Revision of this information will not 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 86, No. 164 / Friday, August 27, 2021 / Notices 48147 

require changes in the scope of the 

project. This Revision includes; (a) 

modification of the Instructions to 

Participants Letter; (b) modification of 

the MPEP Mycobacterium tuberculosis 

Results Worksheet; (c) modification of 

online data collection instrument; (d) 

modification of the MPEP 

Mycobacterium tuberculosis Minimum 

Inhibitory Concentration Results 

Worksheet; (e) removal of Reminder 

Telephone Script; and (f) modification 

of Aggregate Report Letter. 

While the overall number of cases of 

TB in the U.S. has decreased, rates still 

remain high among foreign-born 

persons, corrections, homeless 

populations, and individuals infected 

with HIV in major metropolitan areas. 

To reach the goal of eliminating TB, the 

Model Performance Evaluation Program 

for Mycobacterium tuberculosis 

susceptibility testing is used to monitor 

and evaluate performance and practices 

among US laboratories performing M. 

tuberculosis susceptibility testing. 

Participation in this program is one way 

laboratories can ensure high-quality 

laboratory testing, resulting in accurate 

and reliable testing results. 

By providing an evaluation program 

to assess the ability of laboratories to 

test for drug resistant M. tuberculosis 

strains, CDC gives laboratories a selfassessment tool to aid in optimizing 

their skills in susceptibility testing. The 

information obtained from the 

laboratories on susceptibility practices 

and procedures is used to establish 

variables related to good performance, 

assess training needs, and aid with the 

development of practice standards. 

Participants in this program include 

domestic clinical and public health 

laboratories. Data collection from 

laboratory participants occurs twice per 

year. The data collected in this program 

will include the susceptibility test 

results of primary and secondary drugs, 

drug concentrations, and test methods 

performed by laboratories on a set of 

performance evaluation (PE) isolates. 

The PE isolates are sent to participants 

twice a year, and participants also 

report demographic data such as 

laboratory type and the number of drug 

susceptibility tests performed annually. 

CDC requests approval for an 

estimated 129 burden hours annually. 

There is no cost to respondents to 

participate other than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

Domestic Laboratory ..... Participant Biosafety Compliance Letter of 

Agreement.

80 1 5/60 7 

MPEP Mycobacterium tuberculosis Results 

Worksheet.

80 2 30/60 80 

Online Survey Instrument .................................... 80 2 15/60 40 

MPEP Mycobacterium tuberculosis Minimum Inhibitory Concentration Results Form.4 2 15/60 2 

Total ........................ .............................................................................. ........................ ........................ ........................ 129 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2021–18541 Filed 8–26–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Board of Scientific Counselors, 

National Center for Health Statistics 

(BSC, NCHS) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

CDC announces the following meeting 

for the Board of Scientific Counselors, 

National Center for Health Statistics 

BSC, NCHS). This meeting is open to 

the public. 

DATES: The meeting will be held on 

October 22, 2021, from 11:00 a.m. to 

5:30 p.m., EDT. 

ADDRESSES: Instructions to access the 

meeting are posted on the BSC website: 

https://www.cdc.gov/nchs/about/bsc/ 

bsc_meetings.htm. 

FOR FURTHER INFORMATION CONTACT: 

Rebecca Hines, M.H.S., Executive 

Secretary, NCHS/CDC, Board of 

Scientific Counselors, 3311 Toledo 

Road, Room 2627, Hyattsville, Maryland 

20782, Telephone: (301) 458–4717; 

Email: RSHines@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose: The Board is charged with 

providing advice and making 

recommendations to the Secretary, 

Department of Health and Human 

Services; the Director, CDC; and the 

Director, NCHS, regarding the scientific 

and technical program goals and 

objectives, strategies, and priorities of 

NCHS. 

Matters To Be Considered: The 

meeting agenda includes welcome 

remarks and a Center update by the 

NCHS Director; updates on Data 

Modernization (DMI), including 

Epidemiology and Laboratory Capacity 

for Prevention and Control of Emerging 

Infectious Diseases (ELC) Collaboration; 

an update on the National Center for 

Health Statistics Strategic Planning; 

presentation on the NCHS Health Equity 

Strategy; updates on using the National 

Health Interview Survey (NHIS) as a 

platform for additional data collection; 

and an update on several NCHS 

Programs. Agenda items are subject to 

change as priorities dictate. 

Meeting Information: Please visit the 

BSC website: https://www.cdc.gov/nchs/ 

about/bsc/bsc_meetings.htm for more 

information on the meeting agenda, 

including instructions for accessing the 

live meeting broadcast. 

The Board will reserve time for public 

comment at the end of the day. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 


lotter on DSK11XQN23PROD with NOTICES1